Searching News Database: Berlex
HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
HSMN NewsFeed - 19 Dec 2019
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
HSMN NewsFeed - 4 Feb 2019
Sojournix Appoints Ruth Thieroff-Ekerdt, M.D. As Senior Vice President And Chief Medical Officer
Sojournix Appoints Ruth Thieroff-Ekerdt, M.D. As Senior Vice President And Chief Medical Officer
HSMN NewsFeed - 26 Jun 2017
Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations
Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations
HSMN NewsFeed - 31 Jan 2014
ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
HSMN NewsFeed - 5 Dec 2011
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
HSMN NewsFeed - 3 Nov 2011
Viamet Pharmaceuticals Appoints Former Novartis Executive Marc Rudoltz, M.D. as Chief Medical Officer
Viamet Pharmaceuticals Appoints Former Novartis Executive Marc Rudoltz, M.D. as Chief Medical Officer
HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
HSMN NewsFeed - 8 Nov 2010
ZIOPHARM Oncology Appoints Brian L. Hamilton, M.D., Ph.D., as Senior Vice President, Clinical Operations
ZIOPHARM Oncology Appoints Brian L. Hamilton, M.D., Ph.D., as Senior Vice President, Clinical Operations
HSMN NewsFeed - 21 Sep 2010
Jeffrey A. Winton Named Vice President of Communications at Eli Lilly and Company
Jeffrey A. Winton Named Vice President of Communications at Eli Lilly and Company
HSMN NewsFeed - 16 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
HSMN NewsFeed - 4 Aug 2009
Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
HSMN NewsFeed - 9 Jun 2009
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
HSMN NewsFeed - 10 Dec 2008
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
HSMN NewsFeed - 22 Sep 2008
Medimetriks Pharmaceuticals, Inc. Welcomes Wolfgang Kunze to Its Board of Directors
Medimetriks Pharmaceuticals, Inc. Welcomes Wolfgang Kunze to Its Board of Directors
HSMN NewsFeed - 10 Sep 2008
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
HSMN NewsFeed - 8 Jul 2008
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
HSMN NewsFeed - 25 Mar 2008
Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
HSMN NewsFeed - 10 Oct 2007
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
HSMN NewsFeed - 26 Sep 2007
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
HSMN NewsFeed - 18 Jun 2007
Oculus Innovative Sciences Appoints Vice President of Regulatory Affairs and Quality
Oculus Innovative Sciences Appoints Vice President of Regulatory Affairs and Quality
HSMN NewsFeed - 6 Jun 2007
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
HSMN NewsFeed - 20 Mar 2007
Vidacare(R) Announces Sales and Marketing Leader for New Hematology/Oncology Business Unit
Vidacare(R) Announces Sales and Marketing Leader for New Hematology/Oncology Business Unit
HSMN NewsFeed - 8 Feb 2007
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
HSMN NewsFeed - 1 Feb 2007
VioQuest Pharmaceuticals, Inc. Announces Appointment of Chief Scientific Officer
VioQuest Pharmaceuticals, Inc. Announces Appointment of Chief Scientific Officer
HSMN NewsFeed - 9 Nov 2006
Bayer Outlines New Global R&D Structures; U.S. Pharma Sites and Future Headquarters
Bayer Outlines New Global R&D Structures; U.S. Pharma Sites and Future Headquarters
HSMN NewsFeed - 31 Oct 2006
Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma
Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma
HSMN NewsFeed - 23 Oct 2006
FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
HSMN NewsFeed - 25 Jul 2006
Mylan Announces Final Approval for Additional Strengths of Estradiol Transdermal Systems
Mylan Announces Final Approval for Additional Strengths of Estradiol Transdermal Systems
HSMN NewsFeed - 20 Jul 2006
Berlex Issues Nationwide Recall of a Single Lot of Ultravist(R) Injection 370 mgI/mL, 125 mL in the U.S.
Berlex Issues Nationwide Recall of a Single Lot of Ultravist(R) Injection 370 mgI/mL, 125 mL in the U.S.
HSMN NewsFeed - 7 Jun 2006
Betaferon(R) Approved in Europe as a First-Line Treatment for the Earliest Stages of Multiple Sclerosis
Betaferon(R) Approved in Europe as a First-Line Treatment for the Earliest Stages of Multiple Sclerosis
HSMN NewsFeed - 1 Jun 2006
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
HSMN NewsFeed - 22 May 2006
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
HSMN NewsFeed - 20 Mar 2006
Abraxis Oncology Names Joseph Hogan Vice President of U.S. Sales and Marketing
Abraxis Oncology Names Joseph Hogan Vice President of U.S. Sales and Marketing
HSMN NewsFeed - 17 Mar 2006
FDA Approves YAZ(R), the First Oral Contraceptive to Offer Drospirenone in a 24-Day, Active-Pill Regimen
FDA Approves YAZ(R), the First Oral Contraceptive to Offer Drospirenone in a 24-Day, Active-Pill Regimen
HSMN NewsFeed - 17 Mar 2006
Schering AG Receives FDA Approval for New Low Dose Oral Contraceptive YAZ(R) with 24-day Regimen
Schering AG Receives FDA Approval for New Low Dose Oral Contraceptive YAZ(R) with 24-day Regimen
HSMN NewsFeed - 10 Jan 2006
Berlex Oncology Introduces New Formulation of Leukine(R) With Extended Shelf Life
Berlex Oncology Introduces New Formulation of Leukine(R) With Extended Shelf Life
HSMN NewsFeed - 4 Jan 2006
FDA Approves Osteoporosis Indication for Once-a-Week Hormone Therapy Patch, Climara Pro(R)
FDA Approves Osteoporosis Indication for Once-a-Week Hormone Therapy Patch, Climara Pro(R)
Additional items found! 110
Members Archive contains
110 additional stories matching:
Berlex
(Password required)
Berlex
(Password required)
